Publications
5808 Results
- Journal / Conference
- Journal of the National Cancer Institute, Apr;109(4). pii: djw239.
- Year
- 2017
- Research Committee(s)
- Early Therapeutics and Rare Cancers and Head and Neck
- PMID
- PMID27927756
- PMC
- PMC6059121
- Study Number(s)
- SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)
Surrogate endpoints for overall survival in loco-regionally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis
- Journal / Conference
- Journal of Clinical Oncology, Feb 35(5):499-505
- Year
- 2017
- Research Committee(s)
- Early Therapeutics and Rare Cancers and Head and Neck
- PMID
- PMID27918720
- PMC
- PMC5791836
- Study Number(s)
- SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)
What is the best treatment for locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis
- Journal / Conference
- Leukemia & Lymphoma Aug;58(8):1814-1822
- Year
- 2017
- Research Committee(s)
- Lymphoma
- PMID
- PMID27967294
- PMC
- PMC5502834
- Study Number(s)
- E4494
Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494)
- Journal / Conference
- International Conference on Malignant Lymphoma (June 14-17, 2017, Lugano, Switzerland), oral
- Year
- 2017
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0816
The 23-gene gene expression-based assay does not predict interim PET scan results after ABVD in advanced stage classical Hodgkin lymphoma in the US Intergroup S0816 trial
- Journal / Conference
- International Conference on Malignant Lymphoma (June 14-17, 2017, Lugano, Switzerland), oral presentation
- Year
- 2017
- Research Committee(s)
- Lymphoma
- Study Number(s)
- CTSU/9177
Risk-adapted therapy in adults with burkitt lymphoma: updated results of a multicenter prospective phase II study of DA-EPOCH-R
- Journal / Conference
- Journal Of Oncology Practice
- Year
- 2017
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID28481681
Feasibility of a centralized clinical trials coverage analysis: a joint initiative of the American Society For Clinical Oncology (ASCO) and the National Cancer Institute (NCI) [Special ASCO Report of Joint ASCO/NCI Symposium]
- Journal / Conference
- NPJ Breast Cancer Sep 21;3:37
- Year
- 2017
- Research Committee(s)
- Breast
- PMID
- PMID28948213
- PMC
- PMC5608692
- Study Number(s)
- CTSU/A011401
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer (A011401): Study Design and Rationale
- Journal / Conference
- PLOS Genetics Apr 21;13(4):e1006719
- Year
- 2017
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID28430825
- PMC
- PMC5419479
- Study Number(s)
- S0000
Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African ancestry anthropometry genetics consortium
- Journal / Conference
- Proceedings of the American Association for Cancer Research April Vol 58, abst.1274, page 328; AACR Annual Meeting (April 1-5, 2017, Washington, DC), poster
- Year
- 2017
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Associations between genetic polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Oct;26(10):1549-1557; 2017 Jul 28 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID28754796
- PMC
- PMC5626618
- Study Number(s)
- S0000, SWOG-9217